West Paces Advisors Inc. Eli Lilly & CO Transaction History

West Paces Advisors Inc.

$408 Billion
Q3 2024

A detailed history of West Paces Advisors Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, West Paces Advisors Inc. holds 2,804 shares of LLY stock, worth $2.11 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares

2,804

Previous 2,788 0.57%

Holding current value

$2.11 Million

Previous $2.52 Billion 1.59%

% of portfolio

0.61%

Previous 0.66%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$772.14 - $960.02 $12,354 - $15,360	16 Added 0.57%	2,804 $2.48 Billion
Q2 2024 Jul 16, 2024	SELL	$724.87 - $909.04 $31,169 - $39,088	-43 Reduced 1.52%	2,788 $2.52 Billion
Q1 2024 Apr 15, 2024	SELL	$592.2 - $792.28 $28,425 - $38,029	-48 Reduced 1.67%	2,831 $2.2 Billion
Q4 2023 Jan 30, 2024	SELL	$525.19 - $619.13 $67,224 - $79,248	-128 Reduced 4.26%	2,879 $1.68 Billion
Q3 2023 Dec 18, 2023	SELL	$434.7 - $599.3 $133,452 - $183,985	-307 Reduced 9.26%	3,007 $1.62 Billion
Q2 2023 Dec 18, 2023	SELL	$350.74 - $468.98 $61,730 - $82,540	-176 Reduced 5.04%	3,314 $1.55 Billion
Q1 2023 Dec 18, 2023	SELL	$310.63 - $364.82 $17,395 - $20,429	-56 Reduced 1.58%	3,490 $1.2 Billion
Q4 2022 Dec 18, 2023	BUY	$321.55 - $374.67 $1.14 Million - $1.33 Million	3,546 New	3,546 $1.3 Billion
Q3 2022 Dec 18, 2023	SELL	$296.48 - $337.87 $84,200 - $95,955	-284 Reduced 7.08%	3,727 $1.21 Billion
Q2 2022 Dec 18, 2023	SELL	$278.73 - $327.27 $138,250 - $162,325	-496 Reduced 11.01%	4,011 $1.3 Billion
Q1 2022 Dec 18, 2023	BUY	$234.69 - $291.66 $352,035 - $437,490	1,500 Added 49.88%	4,507 $1.29 Billion
Q4 2021 Dec 19, 2023	SELL	$224.85 - $279.04 $17,988 - $22,323	-80 Reduced 1.79%	4,389 $1.21 Billion
Q3 2021 Dec 19, 2023	BUY	$221.6 - $272.71 $151,352 - $186,260	683 Added 18.04%	4,469 $1.03 Billion
Q2 2021 Dec 19, 2023	SELL	$180.55 - $233.54 $69,150 - $89,445	-383 Reduced 9.19%	3,786 $869 Million
Q1 2021 Dec 19, 2023	BUY	$164.32 - $212.72 $24,155 - $31,269	147 Added 3.65%	4,169 $779 Million
Q4 2020 Dec 19, 2023	BUY	$130.46 - $172.63 $9,654 - $12,774	74 Added 1.87%	4,022 $679 Million
Q3 2020 Dec 19, 2023	SELL	$146.22 - $169.13 $4,094 - $4,735	-28 Reduced 0.7%	3,948 $584 Million
Q2 2020 Dec 19, 2023	BUY	$136.42 - $164.18 $132,190 - $159,090	969 Added 32.22%	3,976 $653 Million
Q1 2020 Dec 20, 2023	BUY	$119.05 - $147.35 $150,241 - $185,955	1,262 Added 49.94%	3,789 $526 Million
Q4 2019 Dec 21, 2023	SELL	$106.92 - $132.43 $10,478 - $12,978	-98 Reduced 2.8%	3,406 $448 Million
Q2 2019 Dec 21, 2023	SELL	$110.79 - $129.32 $7,976 - $9,311	-72 Reduced 2.01%	3,504 $388 Million
Q1 2019 Dec 21, 2023	BUY	$111.31 - $131.02 $120,882 - $142,287	1,086 Added 43.61%	3,576 $464 Million
Q4 2018 Dec 21, 2023	BUY	$105.9 - $118.64 $197,185 - $220,907	1,862 Added 296.5%	2,490 $288 Million
Q3 2018 Dec 20, 2023	SELL	$85.86 - $107.31 $41,212 - $51,508	-480 Reduced 15.96%	2,527 $271 Million
Q2 2018 Dec 21, 2023	BUY	$75.7 - $86.88 $7,570 - $8,688	100 Added 18.94%	628 $53.6 Million
Q1 2018 Dec 21, 2023	SELL	$74.21 - $87.6 $29,683 - $35,040	-400 Reduced 43.1%	528 $40.9 Million
Q4 2017 Dec 21, 2023	BUY	$81.94 - $87.89 $32,776 - $35,156	400 Added 75.76%	928 $78.4 Million
Q4 2016 Dec 21, 2023	SELL	N/A	-2,479	528 $38.8 Million

Others Institutions Holding LLY

# of Institutions

4,029

Shares Held

739M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of West Paces Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on West Paces Advisors Inc. with notifications on news.

Account

West Paces Advisors Inc. Eli Lilly & CO Transaction History